Experience of emergency prevention of measles in children in a specialized institution with 24-hour stay
https://doi.org/10.22627/2072-8107-2025-24-3-44-48
Abstract
Measles is one of the most highly contagious airborne infections. Those who are not vaccinated or have not been ill after contact become ill in almost 100% of cases.
Objective: to evaluate the effectiveness of emergency measles prevention in children in a specialized institution with round-the-clock stay.
Materials and methods: a retrospective analysis of a measles outbreak in a specialized psychoneurological children's home was conducted.
Results: the zero patient was an unvaccinated girl aged 1 year 26 days, who had previously been treated in a hospital for COVID-19, where at the same time measles patients were being treated. She fell ill after 14 days, was re-hospitalized on the 17th day. On the same day, 171 contacts were identified, 7/5.3% of employees were revaccinated with a live measles monovalent vaccine, 10/41.7% of children over 12 months of age received a combined vaccine against measles, rubella and mumps and 14/58.3% of children under 12 months of age received normal human immunoglobulin was administered intramuscularly in 1 dose (1.5 ml). During the period of epidemiological observation, 8/33.3% of children who received emergency prophylaxis fell ill (1/10.0% — trivaccine and 7/50.0% — immunoglobulin). All suffered from typical measles of moderate severity.
Conclusion. The development of the disease in 50.0% of cases with consistent involvement in the epidemic process after passive prophylaxis indicates insufficient effectiveness of the administration of the minimum recommended dose of immunoglobulin.
About the Authors
T. M. ChernovaRussian Federation
Saint Petersburg
V. N. Timchenko
Russian Federation
Saint Petersburg
V. F. Sukhovetskaya
Russian Federation
Saint Petersburg
E. V. Barakina
Russian Federation
Saint Petersburg
A. N. Nazarova
Russian Federation
Saint Petersburg
I. Yu. Bazunova
Russian Federation
Saint Petersburg
A. A. Zherebtsova
Russian Federation
Saint Petersburg
M. A. Shakmaeva
Russian Federation
Saint Petersburg
T. V. Vishnevskaya
Russian Federation
Saint Petersburg
References
1. History of measles vaccination. WHO. 2024. Available from: https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-measles-vaccination
2. Mina MJ, Kula T, Leng Y, Li M, de Vries RD et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019; 366(6465): 599—606. doi: 10.1126/science.aay6485
3. Тikhomirova К.К., Konstantinova Yu.Е., Kharit S.М. Measles, rubella, mumps — problem that occurred again. Zhurnal Poliklinika=Polyclinic Journal. 2020; 4:39—45. (In Russ.)
4. European Region reports highest number of measles cases in more than 25 years — UNICEF, WHO/Europe. Available from: https://www.unicef.org/press-releases/european-region-reports-highest-number-measles-casesmore-25-years-unicef-whoeurope
5. Measles Cases and Outbreaks. CDC, Measles (Rubeola). Available from: https://www.cdc.gov/measles/data-research/index.html
6. O sostoyanii sanitarno-e`pidemiologicheskogo blagopoluchiya naseleniya v Rossijskoj Federacii v 2023 godu: Gosudarstvenny`j doklad. Moskva: Federal`naya sluzhba po nadzoru v sfere zashhity` prav potrebitelej i blagopoluchiya cheloveka, 2024:364. (In Russ.)
7. SanPiN 3.3686-21 «Sanitarno-e`pidemiologicheskie trebovaniya po profilaktike infekcionny`x boleznej» (In Russ.)
8. Gastañaduy PA, Banerjee E, DeBolt Ch, Bravo-Alcántara P, Samad SA et al. Public health responses during measles outbreaks in elimination settings: Strategies and challenges. Hum Vaccin Immunother. 2018; 14(9):2222—2238. doi: 10.1080/21645515.2018.1474310
9. Prikaz Minzdrava Rossii ot 06.12.2021 N 1122n «Ob utverzhdenii nacional`nogo kalendarya profilakticheskix privivok, kalendarya profilakticheskix privivok po e`pidemicheskim pokazaniyam i poryadka provedeniya profilakticheskix privivok» (In Russ.)
10. Bichurina M.A., Timofeeva E.V., Zheleznova N.V., Ignatieva N.A., Shulga S.V., Lyalina L.V., Degtyarev O.V. Measles outbreak in the Children’s Hospital in Saint-Petersburg, 2012. Journal Infectology. 2013; 5(2):96—102. (In Russ.) https://doi.org/10.22625/2072-6732-2013-5-2-96-102
11. Niyazalieva M.S., Isakova Zh.T., Toygombaeva V.S., Zholdoshbekov E.Zh. Epidemiological analysis of measles outbreak in Kyrgyz Republic for the 2018 year. Vestnik Avitsenny [Avicenna Bulletin]. 2019; 21(2):285—90. (In Russ.) doi.org/10.25005/2074-0581-2019-21-2-285-290
12. Lastauka I., Artsiomchyk T., Trubchik O. Measles in a Vaccinated Patient. Clinical Infectology and Parasitology. 2020; 9(1):123—128. (In Russ.) doi: https://doi.org/10.34883/PI.2020.9.1.011
13. Hubiche Th, Brazier C, Vabret A, Reynaud S, Roudiere L, del Giudice P. Measles Transmission in a Fully Vaccinated Closed Cohort Data From a Nosocomial Clustered Cases in a Teenage Psychiatric Unit. Pediatr Infect Dis J. 2019; 38(9):230—232. doi: 10.1097/INF.0000000000002372
14. Tsvirkun O.V., Tikhonova N.T., Turaeva N.V., Gerasimova A.G. Foci of nosocomial measles in Russia in the years 2011—2019. Vopr. prakt. pediatr. (Clinical Practice in Pediatrics). 2021; 16(1):7—13. (In Russ.). doi: 10.20953/1817-7646-2021-1-7-13
15. Arciuolo RJ, Jablonski RR, Zucker JR, Rosen JB. Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013. Clin Infect Dis. 2017; 65(11):1843—1847. doi: 10.1093/cid/cix639
16. Barrabeig I, Rovira A, Rius C, Muñoz P, Soldevila N et al. Effectiveness of measles vaccination for control of exposed children. Pediatr Infect Dis J. 2011; 30(1):78—80. doi: 10.1097/INF.0b013e3181f7001c
17. Bigham M, Murti M, Fung C et al. Estimated protective effectiveness of intramuscular immune serum globulin post-exposure prophylaxis during a measles outbreak in British Columbia, Canada, 2014. Vaccine. 2017; 35: 2723—7.
18. Tunis MC, Salvadori MI, Dubey V, Baclic O. Updated NACI recommendations for measles post-exposure prophylaxis. Can Commun Dis Rep. 2018; 44(9):226—230. doi: 10.14745/ccdr.v44i09a07
19. Montroy J, Yan C, Khan F, Forbes N, Krishnan R et al. Post-exposure prophylaxis for the prevention of measles: A systematic review. Vaccine. 2025; 47: 126706. doi: 10.1016/j.vaccine.2025.126706
20. Matysiak-Klose D, Santibanez S, Schwerdtfeger Ch, Koch Ju, von Bernuth H et al. Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany. Vaccine. 2018; 36(52):7916—7922. https://doi.org/10.1016/j.vaccine.2018.10.070
Review
For citations:
Chernova T.M., Timchenko V.N., Sukhovetskaya V.F., Barakina E.V., Nazarova A.N., Bazunova I.Yu., Zherebtsova A.A., Shakmaeva M.A., Vishnevskaya T.V. Experience of emergency prevention of measles in children in a specialized institution with 24-hour stay. CHILDREN INFECTIONS. 2025;24(3):44-48. (In Russ.) https://doi.org/10.22627/2072-8107-2025-24-3-44-48